Search

everythinglearnresearchcommunity

for

Search:↓

A pregnant woman's skin condition improved after giving birth, possibly due to high estrogen levels during pregnancy.

Certain gene variations may increase the risk of PCOS in South Indian women.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

Birth control pills increase the risk of blood clots, especially within the first year and with certain types.

Finasteride has a higher risk of reproductive side effects than minoxidil.

Hyperpigmentation is common in pregnancy and may not fully fade after birth; melasma, also frequent, can persist but has limited treatment options during pregnancy.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Irregular menstrual cycles in teenagers are linked to a higher risk of polycystic ovary syndrome and metabolic syndrome.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

Women with PCOS in Nigeria have higher heart risk markers, needing early heart health checks.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

Doctors should recognize and treat PCOS early in primary care to manage symptoms and lower risk of other health issues.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

The document concludes that managing PCOS requires a comprehensive approach, including lifestyle changes and medication, to improve symptoms and reduce health risks.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

The article concludes that advancements in hair cosmetics require dermatologists to stay informed about products and their potential risks, including allergies and higher risks for hairdressers.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

Biologics for severe asthma have known side effects, but some new risks need more study.

Alopecia areata patients may have higher blood pressure and blood sugar, indicating a future risk of metabolic issues.

Early detection and comprehensive treatment of PCOS are crucial due to its long-term health impacts and associated risks.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

The document concludes that the fast-growing direct-to-consumer genetic testing market lacks sufficient regulation, posing risks to consumers due to questionable test quality and accuracy.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.